ABBOTT LABORATORIES vs Encompass Health Corporation. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where ABT and EHC diverge most: on implied growth (priced in), ABT reads +9.6% and EHC reads -3.5%; on fcf yield, ABT reads 4.5% and EHC reads -6.7%. The rest of the comparable metrics sit closer together. On valuation, today's ABT price has a different growth bar priced in than EHC (+9.6% implied for ABT vs -3.5% for EHC); the higher figure is the steeper assumption to clear, not a better or worse stock. What ABT's price implies is a bet that sits within the historical range (whole-company basis). What EHC's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | ABT | EHC |
|---|---|---|
| Price | $93.93 | $110.11 |
| Market cap | $164.1B | $11.1B |
| Sector | Drug Manufacturers | Medical Care |
| Stage | Mature | Mature |
| Implied growth (priced in) | +9.6% | -3.5% |
| P/E | 26.3 | 18.4 |
| P/B | 3.11 | 3.35 |
| P/S | 3.64 | 1.83 |
| EV/EBITDA | 20.8 | 40.3 |
| Revenue growth | +6.6% | +10.1% |
| Operating margin | 12.1% | — |
| Net margin | 13.9% | 10.0% |
| Return on equity | 11.9% | 18.4% |
| Return on assets | 5.7% | 8.3% |
| Return on invested capital | 6.6% | — |
| FCF yield | 4.5% | -6.7% |
| Dividend yield | 2.6% | 0.7% |
| Debt / equity | 0.65 | 0.78 |
| Current ratio | 1.39 | 1.17 |
| Altman Z (solvency) | 7.16 | 2.54 |
| Piotroski F (quality) | 6 / 9 | 5 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.